Skip to content

Autologous Fat Grafting With PRP (Platelet Rich Plasma) to Anophthalmic Sockets

Autologous Fat Grafting to Anophthalmic Sockets With PRP (Platelet Rich Plasma) Using a Closed Cannula Technique

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01712555
Enrollment
5
Registered
2012-10-23
Start date
2011-12-31
Completion date
2017-12-15
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orbital Atrophy

Keywords

Anophthalmic orbits, autologous fat, platelet rich plasma, orbital atrophy, anophthalmos, cannula

Brief summary

After people lose an eye, for whatever reason, they often experience fat atrophy of the tissues in the orbit. This leads to a sunken appearance that is often not correctable by a cosmetic shell prosthesis. Current techniques to correct this deformity are inadequate/ invasive. Injection of various gels (Restylane, Radiesse) are temporary had have their own disadvantages. This study seeks to demonstrate an improvement in the retention of injected autologous fat by mixing in autologous PRP (platelet rich plasma).

Interventions

PROCEDUREautologous fat grafting with PRP to anophthalmic orbits

Sponsors

Fox, Donald Munro, M.D., P.C.
Lead SponsorINDIV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

anophthalmos, orbital atrophy -

Exclusion criteria

poor anesthesia risk, people outside a 100 mile radius of New York City \-

Design outcomes

Primary

MeasureTime frameDescription
Improved retention of autologous fat injected into anophthalmic sockets1-5 yrsNon contrast MRIs of the orbits are obtained before, immediately after, and one year after injection of autologous fat mixed with autologous PRP (platelet rich plasma)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026